Philip M Young bought $800K of Carlsmed (CARL)
Executed Jul 24 2025, disclosed Jul 25 2025, the same day.
Over the 21 trading sessions from the disclosed entry session (Jul 24 2025), the stock returned -15.0% (delay-adjusted); from the execution session (Jul 24 2025), -15.0%. Derived: entry at the session's open, exit at the close 20 sessions later.
Philip M Young (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Carlsmed, Inc. (CARL). Across 1 priced purchase filing, the average 21-session return was -15.0% from execution and -15.0% from disclosure (delay-adjusted; derived). The largest single filing was $800K of CARL (53,333 sh × $15.00, as filed), executed Jul 24 2025.
Healthcare · Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery sol…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→